Global Innovative Platforms GIPL
OTC GIPL
$0.50 +0.00 (+0.00%)
At close: Oct 14, 2026 · 4:00 PM EDT

Global Innovative Platforms (GIPL) Accumulated Expenses (2025 - 2026)

Updated

Global Innovative Platforms' Accumulated Expenses was $2,000 in fiscal Q3 2026 (quarter ended Jun 30, 2026), unchanged from the prior quarter.

Analysis

Global Innovative Platforms (GIPL) Accumulated Expenses (2025 - 2026) Analysis & Trends

At the end of FY2025 (ended Sep 30, 2025), Accumulated Expenses at Global Innovative Platforms came in at $10,000.

  • Quarterly Accumulated Expenses has moved between $2,000 (fiscal Q2 2026) and $10,000 (fiscal Q4 2025) over five years.
  • Per Business Quant data, GIPL's Accumulated Expenses in the three fiscal quarters before Q3 2026 was $2,000 (Q2 2026), $7,000 (Q1 2026) and $10,000 (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn
10 Global Innovative Platforms 24.88 Mn 24.27 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2,000.00
Mar 31, 2026 2,000.00
Dec 31, 2025 7,000.00
Sep 30, 2025 10,000.00
API Access

Global Innovative Platforms Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=GIPL&period=max&api_key=YOUR_API_KEY